Atlas Trials

Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors

Clinical trial NCT07189377 · RECRUITING

Trial details

NCT number
NCT07189377
Sponsor
University Health Network, Toronto
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis B Virus (HBV)Lung Transplant Recipient
Start date
2025-09-24
Primary completion
2027-08-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.